OpenAI and Anthropic Could Both Go Public by Year-End. These ETFs Let You Own Them Today.

OpenAI and Anthropic have both filed confidential S-1s, signaling potential IPOs by year-end and increasing investor interest in pre-IPO AI exposure. The article highlights accessible vehicles like KraneShares AGIX, Ark Venture Fund, and Ark Innovation ETF, which hold direct or indirect stakes in OpenAI and Anthropic; AGIX charges 0.99% and ARKK 0.75%, while ARKVX has 8.5% OpenAI and 6.4% Anthropic weights and a $500 minimum. The piece is largely informational but could support demand for AI-themed public-private funds.

Analysis

The market is effectively being handed a pre-IPO wrapper trade on frontier AI: the direct beneficiaries are not the private names themselves, but the public portfolio vehicles that can monetize retail demand for scarcity. That creates a second-order flow effect into GOOGL and AMZN, which already own strategic stakes and can now be re-rated as embedded option holders on a much larger future exit value, even if the private marks remain opaque. NVDA benefits more indirectly: every additional dollar of enthusiasm for model-scale AI raises investor willingness to pay for compute exposure, but the bigger near-term effect is sentiment spillover rather than incremental fundamentals.

The key risk is that the retail-access narrative may outrun realizable mark-to-market economics. Private AI exposure inside an ETF or interval fund is illiquid and prone to stale pricing, so the products can trade on enthusiasm while the underlying position values only reprice at fundraising or IPO milestones over months, not days. If IPO timing slips or the confidential S-1s do not convert into near-term offerings, the trade can unwind as a flow-driven premium rather than a fundamentals-driven one.

Consensus is underestimating dispersion between “AI beta” and “AI access.” Most of the upside from this story accrues to the wrappers with scarce private allocations, not to broad innovation ETFs already crowded with similar public growth names. Conversely, the expensive fee load and liquidity constraints mean the more the market rushes in, the more future returns get transferred from investors to fund sponsors unless the private marks step up materially after listing.

Key Decisions for Investors

• Long GOOGL and AMZN vs. ARKK on a 3-6 month horizon: own the strategic-stake beneficiaries rather than paying high fees for diluted exposure; target a modest 1.5-2.0x upside capture relative to the ETF if IPO hype expands.
• Buy AGIX on weakness only, not strength: use a staggered entry over 2-4 weeks because the premium is flow-sensitive; risk/reward improves if the fund trades at a discount to implied private-mark value.
• Avoid chasing ARKVX near-term; if desired, treat it as a tactical event trade only around confirmed IPO filing milestones, since liquidity gating and redemption windows can force de-risking into weakness.
• Pair long NVDA / short a basket of broad innovation ETFs over 1-2 months if AI enthusiasm accelerates: compute demand is the cleaner fundamental expression, while wrapper funds are more vulnerable to sentiment reversals.
• Set a catalyst alert for actual IPO pricing or amended S-1 disclosure; that is the point where private-mark repricing can justify moving from flow trade to fundamentals trade in the public beneficiaries.